Universal Cell Therapeutics Ltd.
Registered name: UNIVERSAL CELL THERAPEUTICS LTD.
Universal Cell Therapeutics Ltd. does not publish its revenue or profit. Its accounts to 31 Mar 2025 show net assets of -£770.
Universal Cell Therapeutics Ltd. did not publish its revenue or profit — small companies aren’t required to file a profit & loss account. Its accounts for the year to 31 Mar 2025 showed net assets of −£770 and 0 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in Warrington; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Warrington, North West
- Age
- 9 yrs · since 2017
- Type
- Private Limited Company
Key figures
Revenue not disclosed
Universal Cell Therapeutics Ltd.’s accounts for the year to 31 Mar 2025 contain a balance sheet but no profit & loss account, so its revenue and profit are not public. UK small and micro-entity companies are not required to publish a P&L — this is normal and says nothing about how the business is performing.
We never estimate revenue. Below you’ll find the balance-sheet figures that were filed — useful as indirect signals of momentum, but they are not revenue or profit.
- Employees
- 0
- Net assets
- −£770
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Mar 2022 | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 |
|---|---|---|---|---|
| Disclosure | No P&L | Full P&L | Full P&L | No P&L |
| Profit & loss | ||||
| Revenue (turnover) | — | £0 | £0 | — |
| Profit after tax | — | −£886 | £14 | — |
| Profit (best available) | — | −£886 | £14 | — |
| Staff costs | — | £0 | £0 | — |
| Employees (average) | — | 0 | 0 | 0 |
| Ratios | ||||
| Profit margin | — | — | — | — |
| Balance sheet — indirect signals, not revenue | ||||
| Net assets | £100 | −£785 | −£770 | −£770 |
| Fixed assets | — | £4.2k | £6.2k | £6.2k |
| Current assets | £100 | £1k | £100 | £100 |
| Source | FullAccounts · bulk data Dec 2023 | FullAccounts · bulk data Dec 2023 | FullAccounts · bulk data Dec 2024 | FullAccounts · bulk data Dec 2025 |
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now −£770
- Cash at bank
- —
- Now —
- Headcount
- —
- Now 0
- Deferred income
- —
- Now —
- Fixed assets
- 0%
- Now £6.2k
Similar profitable businesses
- Porvair PLCKings Lynn · Manufacture of basic pharmaceutical products
- Revenue
- £194m
- Profit
- £18.2m
- Staff
- 1,011
- RSR LimitedLancaster · Manufacture of basic pharmaceutical products
- Revenue
- £22.2m
- Profit
- £17.7m
- Staff
- 96
- T.G. Eakin LimitedComber · Manufacture of basic pharmaceutical products
- Revenue
- £41.3m
- Profit
- £14m
- Staff
- 155
- Herrco Cosmetics LimitedHalesworth · Manufacture of basic pharmaceutical products
- Revenue
- £40.4m
- Profit
- £5.7m
- Staff
- 179
- Manx Healthcare LimitedWarwick · Manufacture of basic pharmaceutical products
- Revenue
- £12.6m
- Profit
- £5.6m
- Staff
- 31
- West Pharmaceutical Services Cornwall LimitedLondon · Manufacture of basic pharmaceutical products
- Revenue
- £51.3m
- Profit
- £3.6m
- Staff
- 206
Sources
Latest figures from FullAccounts for the year to 31 Mar 2025, from the Companies House accounts bulk data published Dec 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.